A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema

Research output: Contribution to journalArticle (Academic Journal)

Original languageEnglish
Pages (from-to)841-849
JournalOphthalmology
Volume123
Issue number4
Publication statusPublished - 2016

Profiles

Cite this